Steven Cohen's IDXX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 11,204 shares of IDEXX Laboratories, Inc. (IDXX) worth $7.58 M, representing 0.01% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in IDXX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2017, adding 153,100 shares. Largest reduction occurred in Q2 2024, reducing 125,550 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +11,204 | New Buy | 11,204 | $676.53 |
| Q4 2024 | -96,462 | Sold Out | 0 | $0.00 |
| Q3 2024 | +96,462 | New Buy | 96,462 | $505.22 |
| Q2 2024 | -125,550 | Sold Out | 0 | $0.00 |
| Q1 2024 | -14,980 | Reduce 10.66% | 125,550 | $539.93 |
| Q4 2023 | +140,530 | New Buy | 140,530 | $555.05 |
| Q3 2023 | -28,030 | Sold Out | 0 | $0.00 |
| Q2 2023 | -118,818 | Reduce 80.91% | 28,030 | $502.23 |
| Q1 2023 | -8,875 | Reduce 5.70% | 146,848 | $500.08 |
| Q4 2022 | +79,801 | Add 105.11% | 155,723 | $407.96 |
| Q3 2022 | +75,922 | New Buy | 75,922 | $325.79 |
| Q1 2020 | -6,000 | Sold Out | 0 | $0.00 |
| Q4 2019 | +2,800 | Add 87.50% | 6,000 | $261.17 |
| Q3 2019 | -82,873 | Reduce 96.28% | 3,200 | $271.88 |
| Q2 2019 | +86,073 | New Buy | 86,073 | $275.32 |
| Q4 2018 | -3,100 | Sold Out | 0 | $0.00 |
| Q3 2018 | +3,100 | New Buy | 3,100 | $249.68 |
| Q1 2018 | -102,400 | Sold Out | 0 | $0.00 |
| Q4 2017 | -50,700 | Reduce 33.12% | 102,400 | $156.38 |
| Q3 2017 | +153,100 | New Buy | 153,100 | $155.49 |
| Q2 2015 | -4,000 | Sold Out | 0 | $0.00 |
| Q1 2015 | +4,000 | New Buy | 4,000 | $77.25 |
Steven Cohen's IDEXX Laboratories Investment FAQs
Steven Cohen first purchased IDEXX Laboratories, Inc. (IDXX) in Q1 2015, acquiring 4,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held IDEXX Laboratories, Inc. (IDXX) for 22 quarters since Q1 2015.
Steven Cohen's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q3 2017, adding 153,100 shares worth $23.81 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 11,204 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $7.58 M.
As of the Q4 2025 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in IDEXX Laboratories, Inc. (IDXX) was 155,723 shares, as reported at the end of Q4 2022.